Myriad Genetics Inc (NASDAQ:MYGN)
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $806.6M
- Net income
- -$112.6M
- Net margin
- -14.0%
A manageable debt load.
- Total debt
- $210.5M
- Cash
- $115.2M
- Debt / equity
- 0.69
Comfortably covers what is due within a year.
- Current assets
- $289.0M
- Current liabilities
- $130.7M
- Current ratio
- 2.21
Roughly cash-neutral.
- Operating cash flow
- $7.7M
- Free cash flow
- -$8.6M
- FCF margin
- -1.1%
Not funding itself by issuing shares.
- Shares outstanding
- 94.8M
- Share growth (1y)
- 2.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MYGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 190.70 M | 200.40 M | 209.80 M | 205.70 M | 213.10 M | 195.90 M |
| Revenue Growth (YoY) | -10.51 % | 2.30 % | -0.38 % | -3.56 % | 0.76 % | -3.12 % |
| Cost of Revenue | 63.70 M | 62.80 M | 63.00 M | 61.90 M | 61.30 M | 61.70 M |
| Gross Profit | 127.00 M | 137.60 M | 146.80 M | 143.80 M | 151.80 M | 134.20 M |
| SG&A Expense | 140.90 M | 135.80 M | 124.30 M | 138.90 M | 138.70 M | 135.70 M |
| R&D Expense | 25.00 M | 27.10 M | 25.50 M | 28.20 M | 25.60 M | 27.50 M |
| Operating Expenses | 165.90 M | 168.30 M | 152.50 M | 167.10 M | 481.00 M | 163.20 M |
| Operating Income | -38.90 M | -30.70 M | -5.70 M | -23.30 M | -329.20 M | -29.00 M |
| Pretax Income | -42.60 M | -34.10 M | -8.90 M | -26.20 M | -330.60 M | -29.40 M |
| Tax Provision | 600.00 K | 0.00 | -1.00 M | 1.20 M | -100.00 K | -29.30 M |
| Net Income | -43.20 M | -34.10 M | -7.90 M | -27.40 M | -330.50 M | -100.00 K |
| EPS (Basic) | -0.46 | -0.36 | -0.08 | -0.29 | -3.57 | -0.00 |
| EPS (Diluted) | -0.46 | -0.36 | -0.08 | -0.29 | -3.57 | -0.00 |
| Shares Outstanding | 94.80 M | 93.70 M | 93.30 M | 93.10 M | 92.50 M | 91.40 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.